2006 Report on Device Performance from the Independent Panel of Guidant Corporation

This document has been retired.

March 20, 2006—Following the recall event in 2005, the Guidant Corporation commissioned an independent panel charged with studying, analyzing, and evaluating the policies and procedure of the cardiac rhythm management (CRM) business with regard to postmarket device surveillance. This report summarizes the findings and recommendations of the panel.